Počet záznamů: 1
Clinical adenoviral gene therapy for prostate cancer
- 1.
SYSNO ASEP 0351752 Druh ASEP J - Článek v odborném periodiku Zařazení RIV Záznam nebyl označen do RIV Poddruh J Článek ve WOS Název Clinical adenoviral gene therapy for prostate cancer Tvůrce(i) Schenk, E. (NL)
Essand, M. (SE)
Bangma, Ch. H. (NL)
Barber, Ch. (GB)
Behr, J.-P. (FR)
Briggs, S. (GB)
Carlisle, R. (GB)
Cheng, W.-S. (SE)
Danielsson, A. (SE)
Dautzenberg, I. J. C. (NL)
Dzojic, H. (SE)
Erbacher, P. (FR)
Fisher, K. (GB)
Frazier, A. (GB)
Georgopoulos, L. J. (GB)
Hoeben, R. (NL)
Kochanek, S. (DE)
Koppers-Lalic, D. (NL)
Kraaij, R. (NL)
Kreppel, F. (DE)
Lindholm, L. (SE)
Magnusson, M. (SE)
Maitland, N. (GB)
Neuberg, P. (GB)
Nilsson, B. (SE)
Ogris, M. (DE)
Remy, J.-S. (FR)
Scaife, M. (GB)
Schooten, E. (NL)
Seymour, L. (SE)
Totterman, T. (SE)
Uil, T. G. (NL)
Ulbrich, Karel (UMCH-V) RID
Veldhoven-Zweistra, J. L. M. (NL)
de Vrij, J. (NL)
van Weerden, W. (NL)
Wagner, E. (DE)
Willemsen, R. (NL)Zdroj.dok. Human Gene Therapy. - : Mary Ann Liebert - ISSN 1043-0342
Roč. 21, č. 7 (2010), s. 807-813Poč.str. 7 s. Jazyk dok. eng - angličtina Země vyd. US - Spojené státy americké Klíč. slova adenovirus ; gene delivery ; prostate cancer Vědní obor RIV CD - Makromolekulární chemie UT WOS 000279596700003 DOI 10.1089/hum.2009.206 Anotace Prostate cancer is at present the most common malignancy in men in the Western world. When localized, this disease can be treated by curative therapy such as surgery and radiotherapy. Unfortunately, for advanced stage of the disease only palliative treatment is available. Therefore, there is a clinical need for new treatment modalities that can, on the one hand, enhance the cure rate of primary therapy for localized prostate cancer and, on the other hand, improve the treatment of metastasized disease. Gene therapy is now being explored in the clinic as a treatment option for the various stages of prostate cancer. Current clinical experiences are based predominantly on trials with adenoviral vectors. As the first of a trilogy of reviews on the state of the art and future prospects of gene therapy in prostate cancer, this review focuses on the clinical experiences and progress of adenovirus-mediated gene therapy for this disease. Pracoviště Ústav makromolekulární chemie Kontakt Eva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358 Rok sběru 2011
Počet záznamů: 1